P. W. Janssen

Feasibility and implementation of CYP2C19 genotyping in patients using antiplatelet therapy.

F. Asselbergs, D. Claassens, T. Bergmeijer, 2018, Pharmacogenomics.

Effect of CYP3A4*22 and PPAR-α Genetic Variants on Platelet Reactivity in Patients Treated with Clopidogrel and Lipid-Lowering Drugs Undergoing Elective Percutaneous Coronary Intervention

L. Gong, T. Klein, M. Ritchie, 2020, Genes.

Perioperative point of care platelet function testing and postoperative blood loss in high-risk cardiac surgery patients

J. T. ten Berg, J. Kelder, C. Hackeng, 2018, Platelets.

The effect of correcting VerifyNow P2Y12 assay results for hematocrit in patients undergoing percutaneous coronary interventions

T. Bergmeijer, J. T. ten Berg, J. Kelder, 2017, Journal of thrombosis and haemostasis : JTH.

Does percutaneous coronary stent implantation increase platelet reactivity?

J. M. Berg, E. Barbato, J. T. ten Berg, 2017, Blood reviews.

Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres

J. M. Berg, D. Claassens, T. Bergmeijer, 2017, Netherlands Heart Journal.

Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres

J. M. Berg, D. Claassens, T. Bergmeijer, 2017, Netherlands Heart Journal.

Ticagrelor or prasugrel versus clopidogrel in elderly patients with an acute coronary syndrome: Optimization of antiplatelet treatment in patients 70 years and older--rationale and design of the POPular AGE study.

J. Jukema, M. Voskuil, A. V. Van't Hof, 2015, American heart journal.